27 May 2024 : Clinical Research
Percutaneous Coronary Intervention as a Non-Surgical Treatment for Ischemic Mitral Regurgitation in Patients with Multi-Vessel Coronary Artery Disease
Xiaoyan Wang
1ABCE*, Zhihong Liu 1ABCDE, Aoyun Rong 1ABDE, Bofei Ma 1BCDE, Ruixing Mo 1BCEG
DOI: 10.12659/MSM.943122
Med Sci Monit 2024; 30:e943122
Table 3 Surgical risk assessment of the 15 enrolled patients.
| No. | ACEF scores | EuroSCORE (mortality rrojections) | NCDR-CathPCI risk scores |
|---|---|---|---|
| 1 | 1.29 | 11 (15.70%) | 20 (0.3%) |
| 2 | 1.03 | 4 (1.72%) | 30 (1.1%) |
| 3 | 1.00 | 4 (1.72%) | 25 (0.6%) |
| 4 | 1.67 | 11 (12.12%) | 32 (1.1–2.0%) |
| 5 | 1.44 | 10 (12.15%) | 44 (3.6–6.3%) |
| 6 | 1.08 | 4 (2.1%) | 35 (2.0%) |
| 7 | 1.12 | 11 (9.93%) | 29 (0.6–1.1%) |
| 8 | 1.41 | 7 (7.66%) | 20 (0.3%) |
| 9 | 1.23 | 7 (6.36%) | 14 (0.1–0.2%) |
| 10 | 1.53 | 10 (16.04%) | 33 (1.1–2.0%) |
| 11 | 1.19 | 6 (5.61%) | 14 (0.1–0.2%) |
| 12 | 1.28 | 5 (2.72%) | 18 (0.2–0.3%) |
| 13 | 1.22 | 7 (9.18%) | 24 (0.3–0.6%) |
| 14 | 1.55 | 9 (9.02%) | 35 (2.0%) |
| 15 | 1.20 | 6 (5.27%) | 14 (0.1–0.2%) |